Australia's most trusted
source of pharma news
Friday, 19 December 2025
Posted 18 December 2025 AM
A global savings initiative at MSD has hit the ANZ business with an organisational shake-up bringing a mix of promotions, role changes and an undisclosed number of departures.
The restructure comes five months after MSD announced a global multi-year 'optimisation' program that would save the company $US3 billion while shedding 6000 jobs worldwide - or about eight per cent of its workforce.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.